Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Talaris Therapeutics, Inc. | 41,000 | reported | 13 Jun 2023 | tx 17+1,106,365−833,384 |
| TREVENA INC | 8,870 | reported | 20 May 2015 | tx 3+35,481 |
| Moderna, Inc. | 4,185 | reported | 06 May 2026 | tx 19+164,937−39,173 |
| NOVEN PHARMACEUTICALS INC | 0 | reported | 27 Aug 2009 | tx 3+14,591−14,591 |
| NPS PHARMACEUTICALS INC | 0 | reported | 21 Feb 2015 | tx 170+3,462,162−3,075,371 |
| Prevail Therapeutics Inc. | 0 | reported | 22 Jan 2021 | tx 7+40,747−229,941 |
| Baxalta Inc | 0 | reported | 03 Jun 2016 | tx 5+10,460−16,757 |
| ACCELERON PHARMA INC | 0 | reported | 19 Nov 2021 | tx 25+81,808−81,232 |
| ALEXION PHARMACEUTICALS INC | 0 | reported | 21 Jul 2021 | tx 8+13,921−13,921 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 May 2026 | GRANT_AWARD | Moderna, Inc. | 6,454 | 0.00 USD | deriv |
| 06 May 2026 | GRANT_AWARD | Moderna, Inc. | 4,185 | 0.00 USD | deriv |
| 30 Apr 2026 | EXERCISE | Moderna, Inc. | 12,174 | — | |
| 30 Apr 2026 | EXERCISE | Moderna, Inc. | 12,174 | 0.00 USD | deriv |
| 30 Apr 2025 | GRANT_AWARD | Moderna, Inc. | 6,378 | 0.00 USD | deriv |
| 30 Apr 2025 | GRANT_AWARD | Moderna, Inc. | 12,174 | 0.00 USD | deriv |
| 06 May 2024 | GRANT_AWARD | Moderna, Inc. | 7,557 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 41,000 | 0.00 USD | deriv |
| 03 May 2023 | GRANT_AWARD | Moderna, Inc. | 6,134 | 0.00 USD | deriv |
| 20 Jul 2022 | PURCHASE | Talaris Therapeutics, Inc. | 52,000 | 3.62 USD | |
| 25 Jul 2022 | OTHER | Talaris Therapeutics, Inc. | 138,500 | 0.00 USD | |
| 25 Jul 2022 | OTHER | Talaris Therapeutics, Inc. | 138,500 | 0.00 USD | |
| 21 Jul 2022 | PURCHASE | Talaris Therapeutics, Inc. | 36,500 | 3.72 USD | |
| 21 Jul 2022 | OTHER | Talaris Therapeutics, Inc. | 248,432 | 0.00 USD | |
| 21 Jul 2022 | OTHER | Talaris Therapeutics, Inc. | 248,432 | 0.00 USD | |
| 19 Jul 2022 | PURCHASE | Talaris Therapeutics, Inc. | 50,000 | 3.52 USD | |
| 09 Jun 2022 | GRANT_AWARD | Talaris Therapeutics, Inc. | 14,501 | 0.00 USD | deriv |
| 10 May 2022 | EXERCISE | Moderna, Inc. | 23,100 | 18.87 USD | |
| 10 May 2022 | SALE | Moderna, Inc. | 3,196 | 136.10 USD | |
| 10 May 2022 | EXERCISE | Moderna, Inc. | 23,100 | 0.00 USD | deriv |
| 28 Apr 2022 | EXERCISE | Moderna, Inc. | 703 | 0.00 USD | |
| 28 Apr 2022 | EXERCISE | Moderna, Inc. | 703 | 0.00 USD | deriv |
| 28 Apr 2022 | GRANT_AWARD | Moderna, Inc. | 5,415 | 0.00 USD | deriv |
| 15 Dec 2021 | GIFT | Talaris Therapeutics, Inc. | 59,520 | 0.00 USD | |
| 19 Nov 2021 | TENDER | ACCELERON PHARMA INC | 6,749 | — |